• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number NV UNK PIPELINE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Infarction, Cerebral (1771); Death (1802); Thrombus (2101)
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
I.Saatci, k.Yavuz, c.Ozer, s.Geyik, h.S.Cekirge.Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow- up results.American journal of neuroradiology 33 (2012).Doi: 10.3174/ajnr.A3246.Background and purpose: flow-diverting devices now offer a new treatment alternative for cerebral aneurysms.We present the results of a large single-center series of patients treated with the ped, including long-term follow-up.Materials and methods: between november 2008 and september 2011, sidewall aneurysms with a wide neck (greater than or equal to 4 mm) or unfavorable dome-neck ratio (greater than or equal to 1.5); large/giant, fusiform, dissecting, blisterlike, and recurrent sidewall aneurysms; aneurysms at difficult angles; and aneurysms in which a branch was originating directly from the sac were treated with the ped.Patients were premedicated with dual antiplatelet medications.Data, including demographics, aneurysm features, clinical presentation, complications, results, and follow-up information, for up to 2 years are presented.Results: two hundred fifty-one aneurysms in 191 patients were treated.Of these, 96 (38.3%) were large or giant (greater than or equal to 10 mm).In 34/251 (13.5%), peds were used for retreatment.Adjunctive coiling was performed in 11 aneurysms (2.1%).The mean number of devices per aneurysm was 1.3.One aneurysm ruptured in the fourth month posttreatment (0.5%), and symptomatic in-construct stenosis was detected in 1 patient (0.5%) treated with percutaneous transarterial angioplasty.Any event rate was 27/191 (14.1%), with a permanent morbidity of 1% and mortality of 0.5%.Control angiography was available in 182 (95.3%) patients with 239 (95.2%) aneurysms.In 121 aneurysms (48.2%), 1- to 2-year control angiography was available.The aneurysm occlusion rate was 91.2% in 6 months, increasing to 94.6%.Conclusions: use of the ped is safe, efficacious, and durable in cerebral aneurysm treatment, with low morbidity-mortality and high occlusion rates as confirmed with mid- to long-term control angiography.Reported events.- one patient died due to thrombus formation in the right p1, resulting in brain stem infarct after placement of the ped extending from the left posterior cerebral artery to the basilar artery, jailing the right p1, to treat a wide-neck left superior cerebellar artery origin aneurysm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
katcha taylor
9775 toledo way
irvine, CA 92618
9496801345
MDR Report Key10129359
MDR Text Key194359245
Report Number2029214-2020-00527
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeTU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 06/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNV UNK PIPELINE
Device Catalogue NumberNV UNK PIPELINE
Device Lot NumberNOT-REP
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/27/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-